Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes
• 09.02.2025 - Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
• 08.26.2025 - Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss
• 08.12.2025 - Second Quarter 2025 Financial Results Earnings Call
• 08.12.2025 - Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.05.2025 - Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
• 08.04.2025 - Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury

Recent Filings

• 08.26.2025 - 8-K Current report
• 08.15.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - EX-99.1 EX-99.1
• 08.12.2025 - 8-K Current report
• 07.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 8-K Current report